Navigation Links
GenVec Announces Multiple Presentations at the American Society of Tropical Medicine and Hygiene Meeting
Date:12/5/2008

is a biopharmaceutical company developing novel therapeutic drugs and vaccines. GenVec's lead product, TNFerade(TM), is currently in a pivotal clinical study (PACT) in locally advanced pancreatic cancer. Additional clinical trials are in progress in rectal cancer, head and neck cancer, and melanoma. GenVec also uses its proprietary adenovector technology to develop vaccines for infectious diseases including HIV, malaria, foot-and-mouth disease, respiratory syncytial virus (RSV), and influenza. Additional information about GenVec is available at www.genvec.com and in the company's various filings with the Securities and Exchange Commission.

Statements herein relating to future financial or business performance, conditions or strategies and other financial and business matters, including expectations regarding future revenues and operating expenses, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act. GenVec cautions that these forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Factors that may cause actual results to differ materially from the results discussed in the forward-looking statements or historical experience include risks and uncertainties, including the failure by GenVec to secure and maintain relationships with collaborators; risks relating to the early stage of GenVec's product candidates under development; uncertainties relating to clinical trials; risks relating to the commercialization, if any, of GenVec's proposed product candidates; dependence on the efforts of third parties; dependence on intellectual property; and risks that we may lack the financial resources and access to capital to fund our operations. Further information on the factors and risks that could affect GenVec's business, financial conditions and results of operations, are contained in GenVec's filin
'/>"/>

SOURCE GenVec, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team
2. ISTA Pharmaceuticals Announces Phase III Results for Once-Daily Topical Xibrom(TM) 0.09%
3. Kiadis Pharma Announces Positive Clinical Results for ATIR(TM) in Mismatched Bone Marrow Transplantations
4. Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study
5. Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings
6. Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints
7. Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH
8. Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin
9. Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483
10. GeneThera Announces it is Set to Begin Commercial Testing for Johnes Disease as Soon as January, 2009.
11. Medarex Announces Initiation of Phase 1b Clinical Development Program with MDX-1106 for the Treatment of Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... The Indiana Medical Device Manufacturers Council and ... Sciences Policy Forum to state legislators. The new policy ... Diagnostics in Indianapolis and featured ... Ellspermann and State Sen. Brandt Hershman . ... new Learning & Development Center, which is under construction ...
(Date:8/31/2015)... , Aug. 31, 2015  DICOM Grid,  ... today that it was recognized as a semifinalist ... software.  The awards are sponsored by ... related professionals in the medical imaging industry.  Since ... radiology professionals to acknowledge the contributions of their ...
(Date:8/31/2015)... TWINSBURG, Ohio , Aug. 31, 2015 /PRNewswire/ ... and applications, has acquired MACTek Corporation, a leading ... part of Pepperl+Fuchs, strategy to further extend its ... the WirelessHART market.    "We are ... to our existing portfolio," said Jim Bolin ...
Breaking Medicine Technology:Indiana Lt. Gov. Sue Ellspermann and State Sen. Brandt Hershman Kick Off New Life Sciences Policy Series 2Indiana Lt. Gov. Sue Ellspermann and State Sen. Brandt Hershman Kick Off New Life Sciences Policy Series 3DG Suite Nabs "Minnies" Nomination for "Best New Radiology Software" 2
... Tenn. , May 20 /PRNewswire-FirstCall / -- Cumberland Pharmaceuticals Inc. ... acute care and gastroenterology markets, today announced that Chief Commercial Officer ... Global Life Sciences Conference in New York at 11:30 ... , , , ...
... , May 20 LightLab Imaging, Inc. announced today that ... leading interventional cardiologist and Director of the Interventional Cardiovascular Center at University ... available to hospitals in the United States – Optical Coherence ... Dr. Costa ...
Cached Medicine Technology:Cumberland Pharmaceuticals to Present at Jefferies Global Life Sciences Conference in New York on June 8, 2010 2LightLab's C7-XR FD-OCT Intravascular Imaging System Featured on Good Morning America 2LightLab's C7-XR FD-OCT Intravascular Imaging System Featured on Good Morning America 3
(Date:8/31/2015)... ... , ... According to an article published August 3rd on Healio, ... underwent bariatric surgery “felt significantly better two years after surgery.” The article goes on ... study felt that their “mental health had been normalized” at the point when the ...
(Date:8/31/2015)... ... August 31, 2015 , ... Dad Phil, son Scott, ... on Aug. 26, generously hosted by the Collinsville Chamber of Commerce, but the ... Call Center and website since Aug. 17. , The Greens have operated Green ...
(Date:8/31/2015)... Knoxville, TN (PRWEB) , ... August 31, 2015 ... ... of urgent care and accessible primary care, is enhancing its existing presence in ... Pike in Knoxville. The location is the company’s second in Knoxville, sixteenth in ...
(Date:8/31/2015)... ... August 31, 2015 , ... Kognito , a leader ... competencies in managing challenging conversations, announced today that Glenn Albright, Ph.D., the company’s ... Excellence for Psychological Health and Traumatic Brain Injury (DCoE) Summit taking place ...
(Date:8/31/2015)... IL (PRWEB) , ... August 31, 2015 , ... In ... studies, Etymotic Research, maker of the BEAN™ personal sound amplifier, is offering caregivers “7 ... sound amplifiers as a way of coping with a variety of home healthcare challenges, ...
Breaking Medicine News(10 mins):Health News:Article on Adolescent Bariatric Surgery Demonstrates the Powerful Effect of Being in Control, Notes Dr. Michael Feiz 2Health News:Article on Adolescent Bariatric Surgery Demonstrates the Powerful Effect of Being in Control, Notes Dr. Michael Feiz 3Health News:Ribbon Cutting Launches AdvantaClean of Madison County 2Health News:State-of-the-Art Urgent Care Facility Opening in Knoxville 2Health News:Kognito’s Glenn Albright to Present at DCoE Summit 2Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 2Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 3
... YORK (Aug. 21, 2007) -- A breakthrough new ... and adults with a common type of congenital ... to oxygenate blood through the lungs. , The ... the first-ever catheter-based pulmonary valve replacement, is currently ...
... researchers say , WEDNESDAY, Aug. 22 (HealthDay News) -- ... humans with obsessive-compulsive disorder (OCD), scientists report. , The ... cells from producing a protein called SAPAP3, according to ... an important role in the transmission of signals between ...
... a dark side, but also a new way it ... -- It looks like HDL, the "good" cholesterol that ... side. , New research suggests that some people,s HDL ... that certain proteins in HDL can exacerbate vessel damage, ...
... scientists reported findings today demonstrating the presence of Marburg ... of African fruit bat (Rousettus aegyptiacus). , ... study is the first in which RT-PCR and serological ... bat species. The natural reservoir for Marburg virus has ...
... of secondary procedures , , TUESDAY, Aug. 21 (HealthDay News) ... peritonitis may not automatically need to undergo more operations ... In the United States, most surgeons choose to wait ... surgery, said Dr. David Flum, a gastrointestinal surgeon at ...
... highly effective in preventing the behavioral and academic problems ... a five-year study led by researchers at Lehigh Universitys ... and funded by the National Institute of Mental Health ... children aged 3 to 5 who have shown significant ...
Cached Medicine News:Health News:NYC-area 1st: Morgan Stanley Children's Hospital performs transcatheter pulmonary valve replacement 2Health News:When 'Good' Cholesterol Goes Bad 2Health News:Scientists detect presence of marburg virus in african fruit bats 2Health News:One Surgery Often Enough for Peritonitis 2Health News:Nonmedicinal treatment touted for preschoolers with ADHD 2Health News:Nonmedicinal treatment touted for preschoolers with ADHD 3
Distinct male and female designs for proper anatomical fit. Hip and pelvic components sized independently. Rigid posterior tongue minimizes pelvic rotation. Available in black or white plastic. Aggre...
... B3 Triplanar hip joint is ... - extension, abduction - Ad-duction, ... our Boston Post-Op Hip Orthosis. ... custom Hip Spicas in both ...
... advance in walker design in years. A real step ... bearing surfaces of the foot rest on adaptive areas ... heel strike. The footbed in the sole conforms to ... and stability. , ,No leg length discrepancy; Heel ...
... The High Tide walker provides comfortable stability ... of the lower leg, stress fractures of ... fractures of the ankle. Extension pads for ... patients.The shorter Low Tide walker with midcalf ...
Medicine Products: